The Longevity Economy: How the $27 Trillion Aging Market Is Creating New Business Opportunities in 2026
GGI Insights
In January 2025, a 72-year-old retired schoolteacher named Margaret Chen walked into a San Francisco biotech clinic and received her first dose of a senolytic drug in a Phase III clinical trial. The...
Table of contents
What Is the Longevity Economy? Defining the $27 Trillion Opportunity
The Demographic Tipping Point: Baby Boomers Turn 80 in 2026
Healthcare and Biotech: Senolytic Therapies, GLP-1, and Anti-Aging Innovation